Enanta Pharmaceuticals (ENTA) Change in Taxes (2016 - 2025)
Enanta Pharmaceuticals filings provide 12 years of Change in Taxes readings, the most recent being -$65.8 million for Q3 2025.
- On a quarterly basis, Change in Taxes fell 6711.46% to -$65.8 million in Q3 2025 year-over-year; TTM through Dec 2025 was -$32.4 million, a 4669.58% decrease, with the full-year FY2025 number at -$32.0 million, down 3315.98% from a year prior.
- Change in Taxes hit -$65.8 million in Q3 2025 for Enanta Pharmaceuticals, down from $31.9 million in the prior quarter.
- In the past five years, Change in Taxes ranged from a high of $31.9 million in Q2 2025 to a low of -$65.8 million in Q3 2025.
- Median Change in Taxes over the past 5 years was $297000.0 (2024), compared with a mean of -$638842.1.
- The widest YoY moves for Change in Taxes: up 28110.0% in 2023, down 14185.0% in 2023.
- Enanta Pharmaceuticals' Change in Taxes stood at -$8.5 million in 2021, then surged by 99.82% to -$15000.0 in 2022, then soared by 4966.67% to $730000.0 in 2023, then crashed by 39.04% to $445000.0 in 2024, then crashed by 14882.92% to -$65.8 million in 2025.
- The last three reported values for Change in Taxes were -$65.8 million (Q3 2025), $31.9 million (Q2 2025), and $1.4 million (Q1 2025) per Business Quant data.